Zvinyorwa

[30] [Itsva] Analytical Performance Evaluation yeGoldstream Fungus (1-3)-β-D Glucan

[29] Ongororo yeCryptococcus capsular polysaccharide yekuona FungiXpert LFA yekukurumidza kuongororwa kweCryptococcosis.

[28] The Diagnostic Value ye Fully Automatic Instrument ye (1-3) -β-d-glucan Test muVarwere vane Tumor.

[27] Kliniki Yekuita Kuongorora kweNovel Monotest Glactomannan Kuonekwa muKuongororwa kweInvasive Aspergillosis.

[26] Tsvagiridzo pamusoro peDiagnostic Performance yeMazhinji Akasiyana Galactomannan Methodology yeInvasive Aspergillosis.

[25] Lateral Flow Analysis Yakasanganiswa neImmunochromatofraphy Analyzer yeGM Quantative Detection.

[24] Kuenzaniswa kwemaitiro akasiyana emicrobiological ekuongororwa kwePneumocystis jirovecii pneumonia pane bronchoalveolar-lavage fuid.

[23] Kuregeredza Genetic Diversity Kunotadzisa Kuongororwa Panguva YeCryptococcus Infec(2)

[22] Ongororo yeCarbapenem-Resistant KNIVO Detection K-Set yekukurumidza kuonekwa kwecarbapenemases pakati pecarbapenem-resistant gram-negative bacilli.

[21] Kukosha kwekubatanidzwa kwekuonekwa kweCandida mannan uye antibody lateral flow assay ye invasive candidiasis kuongororwa.

[20] Kukosha kwekubatanidzwa kwekuonekwa kweAspergillus antigen uye antibody lateral flow assay ye invasive pulmonary aspergillosis diagnosis.

[19] Novel Diagnostic Method yeFungal Infection - (1,3) -β-D-Glucan Chemiluminescence Immunoassay

[18] Yakazara-Automatic Chemiluminescence Immunoassay System yeAspergillus Galactomannan Detection.

[17] Kuongororwa kwechokwadi kweserum 1,3-β-D-glucan yepneumocystis jiroveci pneumonia, invasive candidiasis, uye invasive aspergillosis kuongorora kwakarongeka uye meta-analysis.

[15] Njodzi dzinokonzeresa kudzoka kwehutachiona hwefungal invasive panguva yechipiri antifungal prophylaxis mune allogeneic hematopoietic stem cell transplant vanogamuchira.

[14] Iyo serum glucan level uye pathological shanduko yeantifungal kurapwa kwepasi rekufema turakiti hutachiona hweCandida albicans.

[13] Kuongororwa kweNovel Plasma (1,3)-β-d-Glucan Detection Assay yeKuongororwa kweCandidemia muPediatric Patients.

[12] Platelet Parameters uye (1, 3) -β-D-Glucan seChiratidzo uye Prognostic Marker yeInvasive Fungal Disease mu Preterm Vacheche.

[11] Kuongorora Kwekuita kweSerum 1,3-Beta-D-Glucan muVarwere vane Invasive Fungal Zvirwere Meta-Kuongorora Kwezvinotarisirwa Cohort Zvidzidzo.

[10] Serum Levels yeLipopolysaccharide uye 1,3-β-D-Glucan Inotaurira Kuoma muVarwere vane Crohn's Disease.

[9] Kubuda kweTR46 Y121F T289A muAspergillus fumigatus Isolate kubva kune Murwere wekuChina.

[8] tatistical assessment yeTachypleus amoebocyte lysate yekukurumidza kuongororwa kwechirwere chefungal chinopinda paICU kuChina.

[6] Diagnostic Performance ye (1-3) -β-D-Glucan Assay muPneumocystitis jirovecii, Invasive Aspergillosis, Mucormycosis, Tuberculosis uye Vatano Vazvipiri.

[5] Diagnostic performance ye (1-3) -β-Dglucan assay mune varwere vane Pneumocystis.

[4] VALUTAZIONE DI UN NUOVO TEST GOLDSTREAM FUNGUS (1,3)-ß-D-Glucano PER LA DIAGNOSTICA DELLE INFEZIONI FUNGINE INVASIVE

[3] VALUTAZIONE DI DUE METODICHE PER IL DOSAGGIO SIERICO DEL 1,3-β-D-GLUCANO IN PAZIENTI A RISCHIO DI INFEZIONI FUNGINE INVASIVE

[2] Kuongororwa kweCrAg lateral flow immunoassay yekuongororwa kwekriptococcal meningitis varwere.

[1] Prognostic kukosha kweserum galactomannan uye (1-3)-beta-D-glucan muvarwere vari muchipatara kuongororwa kwekutanga uye yekutevera mhinduro.